ATS completes acquisition of Avidity Science

FHS
August 27, 2024
10:21 am

ATS Corporation (“ATS”), today announced the successful completion of its acquisition of Avidity Science, LLC (“Avidity”), a growing designer and manufacturer of automated water purification solutions for biomedical and life science applications.

Ginseng’s hidden gems: Rare ginsenosides emerge as potent players in the future of medicine

Review in the Journal of Advanced Research summarizes the properties, applications, and production of rare ginsenosides (RGs), highlighting their potential in treating various diseases including

January 9, 2024

Study alerts transwomen to interpret standard prostate cancer screening guidelines with caution

UCSF-led study alerts transwomen and physicians to interpret standard screening guidelines with caution.

June 29, 2024

Malaysia approves Antengene’s XPOVIO for multiple myeloma

The drug’s introduction in Malaysia is anticipated to bring new therapeutic options to the clinical management of MM. Credit: Pickadook/Shutterstock. Antengene has received approval from

August 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.